A Diabetes (Type 1 & 2) programme at Stem Plus in Sofia is €3,000–€8,000, versus roughly €14,600–€46,000 in the Netherlands. About 2.9h from Amsterdam, inside the EU, visa-free.
If you are researching Diabetes (Type 1 & 2) treatment from the Netherlands, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €14,600–€46,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.
Type 1 and Type 2 diabetes both involve dysfunction of insulin-producing beta cells — Type 1 through autoimmune destruction, Type 2 through insulin resistance and beta-cell exhaustion. Stem-cell research targets both: placental mesenchymal stem cells and fetal-derived stem cells are studied for their potential to differentiate toward insulin-producing cells, support pancreatic tissue, and dampen autoimmunity. In Type 1 the immune-modulating properties may restrain beta-cell attack; in Type 2 the aim is to ease insulin resistance and support residual reserve. Translating stem-cell-derived beta cells into safe, scalable, durable treatment remains a major unsolved scientific challenge, and all current clinical work is early-stage. It is delivered under a physician-led protocol and designed to complement your existing care.
| Netherlands (home) | Stem Plus · EU | |
|---|---|---|
| Diabetes (Type 1 & 2) treatment | €14,600–€46,000 | €3,000–€8,000 |
| Regulation | varies | EU · GMP |
| Flight to Sofia | 2.9h from Amsterdam | — |
This note is general information for planning, not legal or medical advice. Confirm entry rules for your nationality before booking.
Cost ranges are indicative market figures for planning, not quotes.
Medicina rigenerativa certificata GMP nel cuore dell'UE — da 3.000–8.000 €, una frazione dei prezzi USA o tedeschi. Protocolli personalizzati per pazienti da oltre 50 Paesi.
Valutazione medica gratuita